Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
IUBMB CommentsAlso acts on some other alkaloids, including codeine, normorphine and ethylmorphine, but only very slowly on 7,8-saturated derivatives such as dihydromorphine and dihydrocodeine. In the reverse direction, also reduces naloxone to the 6alpha-hydroxy analogue. Activated by 2-sulfanylethan-1-ol (2-mercaptoethanol).
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-indanol + NADP+
1-indanone + NADPH
-
-
-
-
?
3-hydroxyhexobarbital + NADP+
?
-
does not serve as a substrate for guinea pig enzyme
-
-
?
benzenedihydrodiol + NADP+
?
-
-
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
codeine + NADP+
codeinone + NADPH
cyclohexene-2-ol + NADP+
cyclohexene-2-one + NADPH
-
-
-
-
?
dihydrocodeine + NADP+
dihydrocodeinone + NADPH
ethylmorphine + NAD(P)+
?
morphine + NAD(P)+
morphinone + NAD(P)H
-
-
-
-
ir
morphine + NAD+
?
-
-
-
?
morphine + NAD+
morphinone + NADH + H+
J7M9D0
-
-
-
?
morphine + NADP+
morphinone + NADPH
morphine + NADP+
morphinone + NADPH + H+
nalorphine + NAD(P)+
(5alpha)-3-hydroxy-17-(prop-2-en-1-yl)-7,8-didehydro-4,5-epoxymorphinan-6-one + NAD(P)H + H+
naloxone + NAD(P)H
6alpha-naloxol + NADP+
trans-1,4-decalindiol + NADP+
?
-
about 30% of the activity observed with morphine
-
-
?
trans-naphthalene dihydrodiol + NAD+
?
-
-
-
?
trans-naphthalene dihydrodiol + NAD+
? + NADH + H+
J7M9D0
-
-
-
?
additional information
?
-
codeine + NAD(P)+

codeinone + NAD(P)H
-
oxidation at 80% the rate of morphine oxidation
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
oxidation at 80% the rate of morphine oxidation
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
only weak enzyme activity for codeine
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
codeine best substrate
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
-
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
oxidation at 120% the rate of morphine oxidation
at pH 6.5, + NADPH, reduction of codeinone to codeine
r
codeine + NAD(P)+
codeinone + NAD(P)H
-
non-Theorell-Chance sequential ordered mechanism for codeine oxidation at pH 9.5
morphine dehydrogenase follows a Theorell-Chance mechanism for codeinone reduction at pH 7.0
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
-
-
-
?
codeine + NAD(P)+
codeinone + NAD(P)H
-
oxidation at 120% the rate of morphine oxidation
at pH 6.5, + NADPH, reduction of codeinone to codeine
r
codeine + NAD(P)+
codeinone + NAD(P)H
-
non-Theorell-Chance sequential ordered mechanism for codeine oxidation at pH 9.5
morphine dehydrogenase follows a Theorell-Chance mechanism for codeinone reduction at pH 7.0
?
codeine + NADP+

codeinone + NADPH
-
codeine as the sole carbon and energy source
-
?
codeine + NADP+
codeinone + NADPH
-
codeine as the sole carbon and energy source
-
?
dihydrocodeine + NADP+

dihydrocodeinone + NADPH
-
-
-
-
?
dihydrocodeine + NADP+
dihydrocodeinone + NADPH
-
-
-
-
?
dihydrocodeine + NADP+
dihydrocodeinone + NADPH
-
-
-
-
?
dihydrocodeine + NADP+
dihydrocodeinone + NADPH
-
-
-
-
?
dihydrocodeine + NADP+
dihydrocodeinone + NADPH
-
-
-
-
?
ethylmorphine + NAD(P)+

?
-
oxidation at 51% the rate of morphine oxidation
-
-
?
ethylmorphine + NAD(P)+
?
-
-
-
-
?
morphine + NADP+

morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
-
?
morphine + NADP+

morphinone + NADPH + H+
-
-
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
-
production of morphinone demonstrated in vitro experiments
?
morphine + NADP+
morphinone + NADPH + H+
-
-
production of morphinone demonstrated in vitro experiments
?
morphine + NADP+
morphinone + NADPH + H+
-
-
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme activity only with NAD+
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme acitivity with NAD+ four times that with NADP+
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme activity only with NADP+
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme activity only with NADP+
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme activity only with NADP+
-
?
morphine + NADP+
morphinone + NADPH + H+
-
enzyme activity only with NADP+
-
-
?
morphine + NADP+
morphinone + NADPH + H+
-
+ NAD+: enzyme activity ten times that with NADP+
-
?
morphine + NADP+
morphinone + NADPH + H+
-
+ NAD+: enzyme activity ten times that with NADP+
-
?
nalorphine + NAD(P)+

(5alpha)-3-hydroxy-17-(prop-2-en-1-yl)-7,8-didehydro-4,5-epoxymorphinan-6-one + NAD(P)H + H+
-
best substrate, oxidation at 120% the rate of morphine oxidation
-
-
?
nalorphine + NAD(P)+
(5alpha)-3-hydroxy-17-(prop-2-en-1-yl)-7,8-didehydro-4,5-epoxymorphinan-6-one + NAD(P)H + H+
-
best substrate, oxidation at 120% the rate of morphine oxidation
-
-
?
naloxone + NAD(P)H

6alpha-naloxol + NADP+
-
-
stereospecific reduction
?
naloxone + NAD(P)H
6alpha-naloxol + NADP+
-
-
stereospecific reduction
?
naloxone + NADH + H+

?
-
-
-
-
r
naloxone + NADH + H+
?
-
-
-
-
r
normorphine + NAD(P)+

?
-
about 3 times better substrate than morphine
-
-
?
normorphine + NAD(P)+
?
-
about 3 times better substrate than morphine
-
-
?
normorphine + NAD(P)+
?
-
best substrate, oxidation at 139% the rate of morphine oxidation
-
-
?
normorphine + NAD(P)+
?
-
-
-
-
?
additional information

?
-
the enzyme AKR1C34 shows 3alpha/17beta/20alpha-hydroxysteroid dehydrogenase activities, EC 1.1.1.239, detailed overview. Ala54 plays a critical role in non-/recognition of the steroidal substrates. Reaction products identification by thin-layer chromatography (TLC) and liquid chromatography/mass spectrometry (LC/MS)
-
-
?
additional information
?
-
-
the enzyme AKR1C34 shows 3alpha/17beta/20alpha-hydroxysteroid dehydrogenase activities, EC 1.1.1.239, detailed overview. Ala54 plays a critical role in non-/recognition of the steroidal substrates. Reaction products identification by thin-layer chromatography (TLC) and liquid chromatography/mass spectrometry (LC/MS)
-
-
?
additional information
?
-
J7M9D0
the enzyme shows NAD+-dependent dehydrogenase activity towards other nonsteroidal alicyclic alcohols and 3alpha/17beta-hydroxy-C18/C19/C21-steroids, detailed overview
-
-
?
additional information
?
-
-
the enzyme shows NAD+-dependent dehydrogenase activity towards other nonsteroidal alicyclic alcohols and 3alpha/17beta-hydroxy-C18/C19/C21-steroids, detailed overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
codeine + NADP+
codeinone + NADPH
morphine + NAD+
?
-
-
-
?
morphine + NAD+
morphinone + NADH + H+
J7M9D0
-
-
-
?
morphine + NADP+
morphinone + NADPH
codeine + NADP+

codeinone + NADPH
-
codeine as the sole carbon and energy source
-
?
codeine + NADP+
codeinone + NADPH
-
codeine as the sole carbon and energy source
-
?
morphine + NADP+

morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
?
morphine + NADP+
morphinone + NADPH
-
highly specific alkaloid dehydrogenase, oxidizing only the C-6 hydroxy group of morphine and codeine, morphine as the sole carbon and energy source
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NADP+
-
the Pseudomonas enzyme acts only with NADP+
NAD(P)+

-
-
NAD(P)+
-
utilized both with nearly equal efficiency
NAD(P)+
-
NAD+ preferred cofactor
NAD(P)H

-
enzyme specific for the proR hydrogen of NADPH
NAD(P)H
-
NADPH: 2.7 times as effective as NADH
NAD+

J7M9D0
-
NAD+
-
NADP+: only about one-tenth of activity with NAD+
NAD+
-
with NADP+ enzyme activity less than 5% those found with NAD+
additional information

J7M9D0
the rabbit enzyme shows high coenzyme preference for NAD+ over NADP+. Also in the reverse reaction, the enzymes reduces several alpha-dicarbonyl compounds including S-camphorquinone using NADH as the coenzyme, exhibiting low Km values of 0.004-0.006 mM. The reductase activity of the enzyme determined with NADPH as the coenzyme is less than 40% of their NADH-linked activity
-
additional information
-
the rabbit enzyme shows high coenzyme preference for NAD+ over NADP+. Also in the reverse reaction, the enzymes reduces several alpha-dicarbonyl compounds including S-camphorquinone using NADH as the coenzyme, exhibiting low Km values of 0.004-0.006 mM. The reductase activity of the enzyme determined with NADPH as the coenzyme is less than 40% of their NADH-linked activity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5alpha-dihydrotestosterone
5beta-dihydrotestosterone
Barbital
-
1mM, 68% inhibition
CdCl2
-
dithiol modifier, strong competitive inhibitor to cofactor
chenodeoxycholic acid
-
0.1 mM, 24% inhibition
cholic acid
-
0.1 mM, 10% inhibition
epiandrosterone
-
0.1 mM, 77% inhibition
indomethacin
-
1 mM, 84% inhibition
naloxone
-
1mM, 61% inhibition
noranhydroicaritin
J7M9D0
-
p-chloromercuribenzoic acid
pyrazole
-
1 mM, 20% inhibition
5alpha-dihydrotestosterone

-
0.1 mM, complete inhibition
5alpha-dihydrotestosterone
-
-
5beta-dihydrotestosterone

-
0.1 mM, complete inhibition
5beta-dihydrotestosterone
-
-
5beta-dihydrotestosterone
-
-
androsterone

-
0.1 mM, 76% inhibition
CuSO4

-
-
estradiol

-
0.1 mM, complete inhibition
Hexestrol

-
hinokitiol

-
Ketamine

-
-
Ketamine
-
1mM, 60% inhibition
lithocholic acid

-
-
lithocholic acid
-
0.1 mM, 75% inhibition
lithocholic acid
-
moderate inhibitory effect
NEM

-
-
NEM
-
inhibit activity at much higher concentration (e.g. at 1 mM)
p-chloromercuribenzoic acid

-
-
p-chloromercuribenzoic acid
-
-
Phenolphthalein

-
Phenylarsine oxide

-
dithiol modifier, competitive inhibitor to cofactor binding and noncompetitively toward morphine binding
quercetin

-
weak inhibitory effect
quercitrin

-
-
testosterone

-
0.1 mM, 100% inhibition
additional information

-
no inhibition by NEM, PCMB, iodoacetic acid
-
additional information
-
no or weak inhibition by pyrazole, barbital
-
additional information
-
competitive inhibitors: testosterone, 5alpha-androstan-17beta-ol-3-one, 5beta-androsteran-17beta-ol-3-one; no inhibition by indomethacine; no or weak inhibition by pyrazole, barbital
-
additional information
no or poor inhibition by 7-hydroxyflavone, chrysin, quercetin, genistein, galangin, lithocholic acid, and zearalenone
-
additional information
-
no or poor inhibition by 7-hydroxyflavone, chrysin, quercetin, genistein, galangin, lithocholic acid, and zearalenone
-
additional information
-
5beta-dihydrotestosterone, lithocholic acid, androsterone and estradiol inhibit competitively toward morphine binding; little inhibitory effect: indomethacin, prostaglandins E2, D2; no or weak inhibition by pyrazole, barbital
-
additional information
-
no inhibition by EDTA, NEM, hydroxyquinoline
-
additional information
-
competitive inhibition: NADP+ with respect to NADPH, codeine with respect to codeinone
-
additional information
-
no or weak inhibition by pyrazole, barbital
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0032 - 0.037
hinokitiol
0.05
icarisid II
Oryctolagus cuniculus
J7M9D0
above, pH 7.4, 25°C, recombinant enzyme
0.013
ikarisoside A
Oryctolagus cuniculus
J7M9D0
pH 7.4, 25°C, recombinant enzyme
0.02
kaempferol
Oryctolagus cuniculus
J7M9D0
above, pH 7.4, 25°C, recombinant enzyme
0.0064
noranhydroicaritin
Oryctolagus cuniculus
J7M9D0
pH 7.4, 25°C, recombinant enzyme
0.00065 - 0.007
Phenolphthalein
0.026
quercetin
Oryctolagus cuniculus
J7M9D0
pH 7.4, 25°C, recombinant enzyme
0.04
quercitrin
Oryctolagus cuniculus
J7M9D0
pH 7.4, 25°C, recombinant enzyme
0.05
zearalenone
Oryctolagus cuniculus
J7M9D0
above, pH 7.4, 25°C, recombinant enzyme
0.0013
Hexestrol

Mesocricetus auratus
pH 7.4, 25°C, recombinant enzyme
0.073
Hexestrol
Oryctolagus cuniculus
J7M9D0
pH 7.4, 25°C, recombinant enzyme